Meeting Banner
Abstract #0658

In Vivo Assessment of IDH Status in Glioblastoma Using 2D 13C Dynamic CSI of Hyperpolarized &[alpha]-Ketoglutarate

Myriam Marianne Chaumeil1, Peder E.Z. Larson1, Hikari A. I. Yoshihara1, Daniel B. Vigneron1, Sarah J. Nelson1, Russell O. Pieper2, Joanna J. Phillips2, Sabrina M. Ronen1

1Radiology, University of California, San Francisco, San Francisco, CA, United States; 2Neurological Surgery, University of California, San Francisco, San, CA, United States

We previously showed that hyperpolarized &[alpha]-KG was a promising probe to inform on isocitrate dehydrogenase (IDH1) mutational status in cell lysates and live perfused cells. In this study, we translated our methods in vivo and evaluated the potential of hyperpolarized &[alpha]-KG to assess IDH status in orthotopic GBM tumors at clinical field strength. Following injection of hyperpolarized &[alpha]-KG, hyperpolarized 2-hydroxyglutarate formation was detected in IDH-mutant tumors, but not in in IDH wild-type, using 2D 13C dynamic CSI. This initial study demonstrates that HP &[alpha]-KG can inform on IDH mutational status in vivo through the dynamic assessment of its metabolism.

Abstract PDF Presentation Video

Keywords

accumulation acquisition acquisitions agent alternative although amounts anatomical anesthetized animals appeared approaches assess assessed association band bearing beginning biopsy blood blue brain buffer catalyzes catheter cells clinical coding collectively concentration conclude cross dang datasets date decreased detect detected detection development dynamic elevated elsewhere enable enhance enhances enzyme evaluate event every expected experimental fact field final findings focuses formation furthermore generate glutamate glycerol grants grid heterozygous illustrates importantly in vivo included indicate indicates inhibitors initial injected injection inside instruments interestingly interrogation known live material metabolism modeling monitor mutant mutation mutations needed neurological noise nonetheless novel optimize originating outside overlaid patient patients peak perfused permeability polarized post potential previously prior processed produced production promising protocol radical radiology rather rats reported resolution respectively samples schemes section secured situ software solution spectra spectroscopy spore start starting status strength sufficient suggests summarizes supported surrounding system therapeutic transl translate tumor tumors twenty type underneath underwent upgraded vector vessels wild